You are here

P&T News

May 4

Johns Hopkins physicians advocate for changes in how deaths are reported
Uncontrollable gambling, eating, and other behaviors linked with drug
Degradation of tip could cause fracture or separation
Lilly’s investigational drug previously received other FDA designations
New study finds they can live nearly as long as the general population

May 3

NEI-funded study of bevacizumab and ranibizumab examines their effects at five years
Better prevention, care will help cut more infections, said researchers from Penn Medicine and Johns Hopkins
New Company Will Build Upon Strength of Current Therapies for Hemophilia A and B
New CDC data show large percentage of antibiotics misused in outpatient settings

May 2

Allergan’s rosuvastatin calcium joins a $6.5 billion market
Subcutaneous nonopioid relieves pain with less toxicity and abuse potential
First and only FDA-approved drug for Parkinson-associated hallucinations and delusions
Registry will provide long-term safety and effectiveness data
Possible link to long wait times for VA care

April 29

First authorized test from commercial lab in U.S.
Combo treatment with lenalidomide and dexamethasone extends progression-free survival
Topoisomerase 1 inhibitors may blunt inflammatory storms

Pages